Evereklioglu C, Sonmez HK, Sevim DG, Arda H, et al. Adalimumab rapidly controls both anterior and posterior inflammation in patients with ocular Behcet syndrome and non-infectious uveitis refractory to conventional therapy: a prospective, 6-month follow-up investigation. Int Ophthalmol 2023 Aug 9. doi: 10.1007/s10792-023-02846.
PMID: 37555889